Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Hanny Al-Samkari, M.D.

Title
Institution
Department
Address
Phone
Profile Picture

Biography
University of Dayton, Dayton, OHB.S., B.A.05/2007Biology, Chemistry
Washington University School of Medicine, St. Louis, MOM.D.05/2011Medicine
Hospital of the University of Pennsylvania, Philadelphia, PA06/2014Internal Medicine Residency
Hospital of the University of Pennsylvania, Philadelphia, PA06/2015Chief Medical Resident
Dana-Farber Cancer Institute/Massachusetts General Hospital/Brigham & Women's Hospital, Boston, MA06/2018Hematology & Medical Oncology Fellowship
2007
John E. Dlugos, Jr. Memoral Award of Excellence in Biology
2007
Montgomery County Medical Society Award
2007
Carl I. Michaelis Chemistry Scholarship Award
2007
Department of Chemistry Teaching Excellence Award
2007
John C. Johnson Research Award
2008
Antoinette Frances Dames Award in Cell Biology and Physiology
2008
Edmund V. Cowdry Prize in Histology
2010
Doctor Richard S. Brookings Medical School Prize
2010
Alpha Omega Alpha, Honor Medical Society
2011
Missouri State Medical Association Award
2011
American College of Physicians Michael M. Karl, M.D. Book Award
2018
Medical Educators Institute
2019
Blood Advances Editorial Fellowship
2019
HTRS/NASTH Early Career Investigator Award
2019
Young Scholar Award
2019
Clinical and Translational Research Academy
2019
Clinical Research Training Institute
2019
Catalyst Medical Research Investigator Training Award
2020
Scholar Award
2020
Eberhard F. Mammen Young Investigator Award

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. (AL-SAMKARI, HANNY) Aug 1, 2020 - Aug 1, 2024
    Cure HHT Foundation
    HHT Research Award
    Role: Principal Investigator
  2. (AL-SAMKARI, HANNY) Jul 1, 2020 - Jun 30, 2023
    American Society of Hematology
    ASH Scholar Award
    Role: Principal Investigator
  3. (AL-SAMKARI, HANNY) Oct 1, 2019 - Sep 30, 2021
    Harvard Catalyst
    KL2/Catalyst Medical Research Investigator Training Award
    Role: Principal Investigator
  4. (AL-SAMKARI, HANNY) Jul 1, 2018 - Jun 30, 2020
    National Hemophilia Foundation
    NHF-Shire Clinical Fellowship
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Al-Samkari H, Eng W. A precision medicine approach to hereditary hemorrhagic telangiectasia and complex vascular anomalies. J Thromb Haemost. 2022 Mar 28. PMID: 35343049.
    Citations:    Fields:    
  2. Al-Samkari H, van Beers EJ, Morton DH, Eber SW, Chonat S, Kuo KHM, Kollmar N, Wang H, Breakey VR, Sheth S, Sharma M, Forbes PW, Klaassen RJ, Grace RF. Health-related quality of life and fatigue in children and adults with pyruvate kinase deficiency. Blood Adv. 2022 Mar 22; 6(6):1844-1853. PMID: 34470054.
    Citations: 1     Fields:    
  3. Lee EJ, Beltrami-Moreira M, Al-Samkari H, Cuker A, DiRaimo J, Gernsheimer T, Kruse A, Kessler C, Kruse C, Leavitt AD, Lee AI, Liebman HA, Newland AC, Ray AE, Tarantino MD, Thachil J, Kuter DJ, Cines DB, Bussel JB. SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP. Blood. 2022 03 10; 139(10):1564-1574. PMID: 34587251.
    Citations: 4     Fields:    
  4. Watson N, Al-Samkari H. Eptacog beta, a novel recombinant factor VIIa, for the treatment of hemophilia. Drugs Today (Barc). 2022 Mar; 58(3):105-116. PMID: 35274630.
    Citations:    Fields:    
  5. Al-Samkari H, Kolb-Sielecki J, Safina SZ, Xue X, Jamieson BD. Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Haematol. 2022 Mar; 9(3):e179-e189. PMID: 35240074.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  6. Al-Samkari H. Systemic Antiangiogenic Therapies for Bleeding in Hereditary Hemorrhagic Telangiectasia: A Practical, Evidence-Based Guide for Clinicians. Semin Thromb Hemost. 2022 Feb 28. PMID: 35226946.
    Citations:    Fields:    
  7. Al-Samkari H, Jiang D, Gernsheimer T, Liebman H, Lee S, Wojdyla M, Vredenburg M, Cuker A. Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study. Br J Haematol. 2022 Feb 18. PMID: 35179784.
    Citations:    Fields:    
  8. Ayad N, Grace RF, Al-Samkari H. Thrombopoietin receptor agonists and rituximab for treatment of pediatric immune thrombocytopenia: A systematic review and meta-analysis of prospective clinical trials. Pediatr Blood Cancer. 2022 Mar; 69(3):e29447. PMID: 34962697.
    Citations:    Fields:    
  9. Al-Samkari H. Platelet clump visible to the naked eye in type 2B von Willebrand disease. Blood. 2021 12 23; 138(25):2742. PMID: 34940814.
    Citations:    Fields:    Translation:HumansCells
  10. Al-Samkari H, van Beers EJ. Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias. Ther Adv Hematol. 2021; 12:20406207211066070. PMID: 34987744.
    Citations:    
  11. Al-Samkari H, Ozonoff A, Landschaft A, Kimia R, Harper MB, Croteau SE, Kimia AA. Utility of Blood Cultures and Empiric Antibiotics in Febrile Pediatric Hemophilia Patients With Central Venous Access Devices. Pediatr Emerg Care. 2021 Dec 01; 37(12):e1531-e1534. PMID: 32349076.
    Citations:    Fields:    Translation:Humans
  12. Douin DJ, Shaefi S, Brenner SK, Gupta S, Park I, Wright FL, Mathews KS, Chan L, Al-Samkari H, Orfanos S, Radbel J, Leaf DE. Tissue Plasminogen Activator in Critically Ill Adults with COVID-19. Ann Am Thorac Soc. 2021 11; 18(11):1917-1921. PMID: 33872546.
    Citations: 3     Fields:    Translation:Humans
  13. Cheloff AZ, Song AB, D'Silva KM, Al-Samkari H. Systemic bevacizumab to facilitate anticoagulation in antiphospholipid syndrome and bleeding gastrointestinal angiodysplasia. J Thromb Thrombolysis. 2022 Apr; 53(3):708-711. PMID: 34694540.
    Citations:    Fields:    
  14. Park AK, Waheed A, Forst DA, Al-Samkari H. Characterization and Prognosis of Temozolomide-Induced Aplastic Anemia in Patients with Central Nervous System Malignancies. Neuro Oncol. 2021 Oct 14. PMID: 34647594.
    Citations:    Fields:    
  15. Song AB, Sakhuja R, Gracin NM, Weinger R, Kasthuri RS, Al-Samkari H. Systemic bevacizumab for refractory bleeding and transfusion-dependent anemia in Heyde syndrome. Blood Adv. 2021 10 12; 5(19):3850-3854. PMID: 34500461.
    Citations:    Fields:    Translation:Humans
  16. Virk ZM, Patel AA, Leaf RK, Al-Samkari H. Predictors of mortality and outcomes of liver transplant in spur cell hemolytic anemia. Am J Hematol. 2021 12 01; 96(12):1611-1620. PMID: 34553418.
    Citations:    Fields:    Translation:Humans
  17. Lee EJ, Al-Samkari H. TPO versus TPO: the good, the bad, and the to be determined. Br J Haematol. 2021 12; 195(5):653-654. PMID: 34618357.
    Citations:    Fields:    Translation:Humans
  18. Gadi SRV, Brunker PAR, Al-Samkari H, Sykes DB, Saff RR, Lo J, Bendapudi P, Leaf DE, Leaf RK. Severe autoimmune hemolytic anemia following receipt of SARS-CoV-2 mRNA vaccine. Transfusion. 2021 11; 61(11):3267-3271. PMID: 34549821.
    Citations: 3     Fields:    Translation:HumansCells
  19. Al-Samkari H, Leaf RK, Goodarzi K. Transient Thrombocytopenia With Glycoprotein-Specific Platelet Autoantibodies After Ad26.COV2.S Vaccination: A Case Report. Ann Intern Med. 2021 11; 174(11):1632-1633. PMID: 34516272.
    Citations: 1     Fields:    Translation:Humans
  20. Song AB, Goodarzi K, Karp Leaf R, Kuter DJ, Al-Samkari H. Thrombopoietin level predicts response to treatment with romiplostim in chemotherapy-induced thrombocytopenia. Am J Hematol. 2021 12 01; 96(12):1563-1568. PMID: 34453757.
    Citations:    Fields:    Translation:Humans
  21. Al-Samkari H. Recognition and management of vascular lesions in von Willebrand disease. J Thromb Haemost. 2021 09; 19(9):2122-2124. PMID: 34435430.
    Citations:    Fields:    Translation:Humans
  22. Harris EM, Hillier K, Al-Samkari H, Berbert L, Grace RF. Response to rituximab in children and adults with immune thrombocytopenia (ITP). Res Pract Thromb Haemost. 2021 Aug; 5(6):e12587. PMID: 34466770.
    Citations:    
  23. Leiva O, Baker O, Jenkins A, Brunner AM, Al-Samkari H, Leaf RK, Rosovsky RP, Fathi AT, Weitzman J, Bornikova L, Nardi V, Hobbs GS. Association of Thrombosis With Hypereosinophilic Syndrome in Patients With Genetic Alterations. JAMA Netw Open. 2021 08 02; 4(8):e2119812. PMID: 34357393.
    Citations:    Fields:    Translation:Humans
  24. Al-Samkari H, Kasthuri RS, Parambil JG, Albitar HA, Almodallal YA, Vázquez C, Serra MM, Dupuis-Girod S, Wilsen CB, McWilliams JP, Fountain EH, Gossage JR, Weiss CR, Latif MA, Issachar A, Mei-Zahav M, Meek ME, Conrad M, Rodriguez-Lopez J, Kuter DJ, Iyer VN. An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study. Haematologica. 2021 08 01; 106(8):2161-2169. PMID: 32675221.
    Citations: 11     Fields:    Translation:Humans
  25. Song F, Al-Samkari H. Management of Adult Patients with Immune Thrombocytopenia (ITP): A Review on Current Guidance and Experience from Clinical Practice. J Blood Med. 2021; 12:653-664. PMID: 34345191.
    Citations: 2     
  26. Parambil JG, Gossage JR, McCrae KR, Woodard TD, Menon KVN, Timmerman KL, Pederson DP, Sprecher DL, Al-Samkari H. Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia. Angiogenesis. 2022 02; 25(1):87-97. PMID: 34292451.
    Citations:    Fields:    Translation:Humans
  27. Al-Samkari H. Giving hereditary haemorrhagic telangiectasia the attention it deserves. Lancet Haematol. 2021 07; 8(7):e472-e474. PMID: 34171274.
    Citations:    Fields:    Translation:Humans
  28. Al-Samkari H, Cronin A, Arnold DM, Rodeghiero F, Grace RF. Extensive variability in platelet, bleeding, and QOL outcome measures in adult and pediatric ITP: Communication from the ISTH SSC subcommittee on platelet immunology. J Thromb Haemost. 2021 09; 19(9):2348-2354. PMID: 33974336.
    Citations: 1     Fields:    Translation:Humans
  29. Sporn ZA, Fenves AZ, Sykes DB, Al-Samkari H. Severe babesiosis with associated splenic infarcts and asplenia. Proc (Bayl Univ Med Cent). 2021 Sep; 34(5):597-599. PMID: 34456483.
    Citations:    
  30. Watson N, Al-Samkari H. Thrombotic and bleeding risk of angiogenesis inhibitors in patients with and without malignancy. J Thromb Haemost. 2021 08; 19(8):1852-1863. PMID: 33928747.
    Citations: 1     Fields:    Translation:Humans
  31. Al-Samkari H, Soff GA. Clinical challenges and promising therapies for chemotherapy-induced thrombocytopenia. Expert Rev Hematol. 2021 05; 14(5):437-448. PMID: 33926362.
    Citations:    Fields:    Translation:Humans
  32. Short SAP, Gupta S, Brenner SK, Hayek SS, Srivastava A, Shaefi S, Singh H, Wu B, Bagchi A, Al-Samkari H, Dy R, Wilkinson K, Zakai NA, Leaf DE. d-dimer and Death in Critically Ill Patients With Coronavirus Disease 2019. Crit Care Med. 2021 05 01; 49(5):e500-e511. PMID: 33591017.
    Citations: 8     Fields:    Translation:HumansCells
  33. Al-Samkari H. Finding the Optimal Thromboprophylaxis Dose in Patients With COVID-19. JAMA. 2021 04 27; 325(16):1613-1615. PMID: 33734290.
    Citations: 4     Fields:    Translation:HumansCells
  34. Al-Samkari H, Parnes AD, Goodarzi K, Weitzman JI, Connors JM, Kuter DJ. A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies. Haematologica. 2021 04 01; 106(4):1148-1157. PMID: 32499239.
    Citations: 8     Fields:    Translation:Humans
  35. Al-Samkari H, Kessler CM, Auerbach M. Recognition of thrombotic risk of thrombocytosis in iron deficiency Haematologica. 2021 03 01; 106(3):661-663. PMID: 33645945.
    Citations:    Fields:    Translation:Animals
  36. Al-Samkari H. Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care. Blood. 2021 02 18; 137(7):888-895. PMID: 33171488.
    Citations: 3     Fields:    Translation:Humans
  37. Al-Samkari H, Nagalla S. Efficacy and safety evaluation of avatrombopag in immune thrombocytopenia: analyses of a phase III study and long-term extension. Platelets. 2022 Feb 17; 33(2):257-264. PMID: 33586606.
    Citations: 2     Fields:    Translation:CTClinical Trials
  38. Al-Samkari H, Gupta S, Leaf RK, Wang W, Rosovsky RP, Brenner SK, Hayek SS, Berlin H, Kapoor R, Shaefi S, Melamed ML, Sutherland A, Radbel J, Green A, Garibaldi BT, Srivastava A, Leonberg-Yoo A, Shehata AM, Flythe JE, Rashidi A, Goyal N, Chan L, Mathews KS, Hedayati SS, Dy R, Toth-Manikowski SM, Zhang J, Mallappallil M, Redfern RE, Bansal AD, Short SAP, Vangel MG, Admon AJ, Semler MW, Bauer KA, Hernán MA, Leaf DE. Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19. Ann Intern Med. 2021 05; 174(5):622-632. PMID: 33493012.
    Citations: 21     Fields:    Translation:HumansCells
  39. Boscoe AN, Yan Y, Hedgeman E, van Beers EJ, Al-Samkari H, Barcellini W, Eber SW, Glader B, Yaish HM, Chonat S, Sharma M, Kuo KHM, Neufeld EJ, Wang H, Verhovsek M, Sheth S, Grace RF. Comorbidities and complications in adults with pyruvate kinase deficiency. Eur J Haematol. 2021 Apr; 106(4):484-492. PMID: 33370479.
    Citations: 4     Fields:    Translation:Humans
  40. Lindquist I, Olson SR, Li A, Al-Samkari H, Jou JH, McCarty OJT, Shatzel JJ. The efficacy and safety of thrombopoietin receptor agonists in patients with chronic liver disease undergoing elective procedures: a systematic review and meta-analysis. Platelets. 2022 Jan 02; 33(1):66-72. PMID: 33459573.
    Citations: 3     Fields:    Translation:Humans
  41. Al-Samkari H. New therapeutic horizons in Wiskott-Aldriech syndrome. Br J Haematol. 2021 01; 192(2):231-232. PMID: 33280084.
    Citations:    Fields:    Translation:Humans
  42. Virk ZM, Kuter DJ, Al-Samkari H. An evaluation of avatrombopag for the treatment of thrombocytopenia. Expert Opin Pharmacother. 2021 Feb; 22(3):273-280. PMID: 33095074.
    Citations: 2     Fields:    Translation:Humans
  43. Leiva O, Newcomb R, Connors JM, Al-Samkari H. Cancer and thrombosis: new insights to an old problem. J Med Vasc. 2020 Nov; 45(6S):6S8-6S16. PMID: 33276943.
    Citations: 7     Fields:    Translation:Humans
  44. Al-Samkari H, Naik RP, Zakai NA. A hematologic support score for longitudinal measurement of blood and iron requirements in hereditary hemorrhagic telangiectasia and other chronic bleeding disorders. Res Pract Thromb Haemost. 2020 Nov; 4(8):1340-1342. PMID: 33313473.
    Citations:    
  45. Al-Samkari H, Croteau SE. Beliefs, opinions and impact of emicizumab in haemophilia A patients: A National US Survey Study. Haemophilia. 2021 Mar; 27(2):e270-e273. PMID: 32897603.
    Citations:    Fields:    Translation:Humans
  46. Faughnan ME, Mager JJ, Hetts SW, Palda VA, Lang-Robertson K, Buscarini E, Deslandres E, Kasthuri RS, Lausman A, Poetker D, Ratjen F, Chesnutt MS, Clancy M, Whitehead KJ, Al-Samkari H, Chakinala M, Conrad M, Cortes D, Crocione C, Darling J, de Gussem E, Derksen C, Dupuis-Girod S, Foy P, Geisthoff U, Gossage JR, Hammill A, Heimdal K, Henderson K, Iyer VN, Kjeldsen AD, Komiyama M, Korenblatt K, McDonald J, McMahon J, McWilliams J, Meek ME, Mei-Zahav M, Olitsky S, Palmer S, Pantalone R, Piccirillo JF, Plahn B, Porteous MEM, Post MC, Radovanovic I, Rochon PJ, Rodriguez-Lopez J, Sabba C, Serra M, Shovlin C, Sprecher D, White AJ, Winship I, Zarrabeitia R. Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. Ann Intern Med. 2020 12 15; 173(12):989-1001. PMID: 32894695.
    Citations: 28     Fields:    Translation:Humans
  47. Al-Samkari H, Song F, Van Cott EM, Kuter DJ, Rosovsky R. Evaluation of the prothrombin fragment 1.2 in patients with coronavirus disease 2019 (COVID-19). Am J Hematol. 2020 12; 95(12):1479-1485. PMID: 32780525.
    Citations: 9     Fields:    Translation:HumansCells
  48. Al-Samkari H, Van Beers EJ, Kuo KHM, Barcellini W, Bianchi P, Glenthøj A, Del Mar Mañú Pereira M, Van Wijk R, Glader B, Grace RF. The variable manifestations of disease in pyruvate kinase deficiency and their management. Haematologica. 2020 09 01; 105(9):2229-2239. PMID: 33054048.
    Citations: 10     Fields:    Translation:HumansCells
  49. Leaf RK, Al-Samkari H, Brenner SK, Gupta S, Leaf DE. ABO phenotype and death in critically ill patients with COVID-19. Br J Haematol. 2020 08; 190(4):e204-e208. PMID: 32609874.
    Citations: 26     Fields:    Translation:HumansCellsCTClinical Trials
  50. Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JCT, Fogerty AE, Waheed A, Goodarzi K, Bendapudi PK, Bornikova L, Gupta S, Leaf DE, Kuter DJ, Rosovsky RP. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020 07 23; 136(4):489-500. PMID: 32492712.
    Citations: 368     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
  51. Al-Samkari H, Goodarzi K. An Eltrombopag Red (Plasma) Alert. Acta Haematol. 2021; 144(2):227-228. PMID: 32702690.
    Citations:    Fields:    Translation:Humans
  52. Leiva O, Connors JM, Al-Samkari H. Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer Patients. Cancers (Basel). 2020 Jul 19; 12(7). PMID: 32707653.
    Citations: 7     
  53. Song AB, Kuter DJ, Al-Samkari H. Characterization of the rate, predictors, and thrombotic complications of thrombocytosis in iron deficiency anemia. Am J Hematol. 2020 Jul 03. PMID: 32619079.
    Citations: 7     Fields:    
  54. Al-Samkari H, van Beers EJ, Morton DH, Barcellini W, Eber SW, Glader B, Yaish HM, Chonat S, Kuo KHM, Kollmar N, Despotovic JM, Pospíšilová D, Knoll CM, Kwiatkowski JL, Pastore YD, Thompson AA, Wlodarski MW, Ravindranath Y, Rothman JA, Wang H, Holzhauer S, Breakey VR, Verhovsek MM, Kunz J, Sheth S, Sharma M, Rose MJ, Bradeen HA, McNaull MN, Addonizio K, Al-Sayegh H, London WB, Grace RF. Characterization of the severe phenotype of pyruvate kinase deficiency. Am J Hematol. 2020 Jul 03. PMID: 32619047.
    Citations: 1     Fields:    
  55. Cheloff AZ, Al-Samkari H. Emapalumab for the treatment of hemophagocytic lymphohistiocytosis. Drugs Today (Barc). 2020 Jul; 56(7):439-446. PMID: 32648854.
    Citations: 2     Fields:    Translation:Humans
  56. Cheloff AZ, Kuter DJ, Al-Samkari H. Serum complement levels in immune thrombocytopenia: Characterization and relation to clinical features. Res Pract Thromb Haemost. 2020 Jul; 4(5):807-812. PMID: 32685889.
    Citations: 3     
  57. Al-Samkari H, Addonizio K, Glader B, Morton DH, Chonat S, Thompson AA, Kuo KHM, Ravindranath Y, Wang H, Rothman JA, Kwiatkowski JL, Kung C, Kosinski PA, Al-Sayegh H, London WB, Grace RF. The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency. Br J Haematol. 2021 03; 192(6):1092-1096. PMID: 32463523.
    Citations: 3     Fields:    Translation:HumansCellsCTClinical Trials
  58. Al-Samkari H, Albitar HA, Olitsky SE, Clancy MS, Iyer VN. An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia. Haemophilia. 2020 Nov; 26(6):1038-1045. PMID: 32432841.
    Citations: 5     Fields:    Translation:Humans
  59. Al-Samkari H, Leiva O, Dagogo-Jack I, Shaw A, Lennerz J, Iafrate AJ, Bendapudi PK, Connors JM. Impact of ALK Rearrangement on Venous and Arterial Thrombotic Risk in NSCLC. J Thorac Oncol. 2020 09; 15(9):1497-1506. PMID: 32437899.
    Citations: 9     Fields:    Translation:Humans
  60. Al-Samkari H, Grace RF, Kuter DJ. The role of romiplostim for pediatric patients with immune thrombocytopenia. Ther Adv Hematol. 2020; 11:2040620720912992. PMID: 32523658.
    Citations: 3     
  61. Al-Samkari H, van Beers EJ, Kuo KHM, Barcellini W, Bianchi P, Glenthøj AB, Mañú-Pereira M, van Wijk R, Glader B, Grace RF. The variable manifestations of disease in pyruvate kinase deficiency and their management. Haematologica. 2020 Mar 12. PMID: 32165483.
    Citations:    Fields:    
  62. Al-Samkari H, Patel AA. How to focus our efforts in improving prognostic disclosure in oncology. Cancer. 2020 06 01; 126(11):2716-2717. PMID: 32073651.
    Citations:    Fields:    Translation:Humans
  63. Boyajian MK, Al-Samkari H, Nguyen DC, Naidoo S, Woo AS. Partial Suture Fusion in Nonsyndromic Single-Suture Craniosynostosis. Cleft Palate Craniofac J. 2020 04; 57(4):499-505. PMID: 32013562.
    Citations:    Fields:    Translation:Humans
  64. Koehl JL, Hayes BD, Al-Samkari H, Rosovsky R. A comprehensive evaluation of apixaban in the treatment of venous thromboembolism. Expert Rev Hematol. 2020 02; 13(2):155-173. PMID: 31958251.
    Citations:    Fields:    Translation:Humans
  65. Al-Samkari H, Rosovsky RP, Karp Leaf RS, Smith DB, Goodarzi K, Fogerty AE, Sykes DB, Kuter DJ. A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia. Blood Adv. 2020 01 14; 4(1):9-18. PMID: 31891657.
    Citations: 13     Fields:    Translation:Humans
  66. Bloom PP, Rodriguez-Lopez J, Witkin AS, Al-Samkari H, Kuter DJ, Mojtahed A, Luther J. Ammonia Predicts Hepatic Involvement and Pulmonary Hypertension in Patients With Hereditary Hemorrhagic Telangiectasia. Clin Transl Gastroenterol. 2020 01; 11(1):e00118. PMID: 31977452.
    Citations:    Fields:    Translation:Humans
  67. Cai J, Ribkoff J, Olson S, Raghunathan V, Al-Samkari H, DeLoughery TG, Shatzel JJ. The many roles of tranexamic acid: An overview of the clinical indications for TXA in medical and surgical patients. Eur J Haematol. 2020 Feb; 104(2):79-87. PMID: 31729076.
    Citations: 22     Fields:    Translation:Humans
  68. Al-Samkari H, Kuter DJ. Immune Thrombocytopenia in Adults: Modern Approaches to Diagnosis and Treatment. Semin Thromb Hemost. 2020 Apr; 46(3):275-288. PMID: 31830764.
    Citations: 8     Fields:    Translation:Humans
  69. Al-Samkari H, Connors JM. Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy. Hematology Am Soc Hematol Educ Program. 2019 12 06; 2019(1):71-79. PMID: 31808892.
    Citations: 1     Fields:    Translation:Humans
  70. Al-Samkari H. Striving for full disclosure-An intergenerational challenge. Cancer. 2020 03 15; 126(6):1150-1151. PMID: 31774549.
    Citations: 2     Fields:    Translation:Humans
  71. Al-Samkari H, Connors JM. Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy. Blood Adv. 2019 11 26; 3(22):3770-3779. PMID: 31770442.
    Citations: 10     Fields:    Translation:Humans
  72. Hollenhorst MA, Al-Samkari H, Kuter DJ. Markers of autoimmunity in immune thrombocytopenia: prevalence and prognostic significance. Blood Adv. 2019 11 26; 3(22):3515-3521. PMID: 31730698.
    Citations: 7     Fields:    Translation:Humans
  73. Al-Samkari H, Albitar HA, Olitsky SE, Clancy MS, Iyer VN. Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers. Orphanet J Rare Dis. 2019 11 14; 14(1):256. PMID: 31727111.
    Citations: 10     Fields:    Translation:Humans
  74. Stern RM, Al-Samkari H, Connors JM. Thrombophilia evaluation in pulmonary embolism. Curr Opin Cardiol. 2019 11; 34(6):603-609. PMID: 31389825.
    Citations: 2     Fields:    Translation:Humans
  75. Al-Samkari H, Kuter DJ. Lactate dehydrogenase is elevated in immune thrombocytopenia and inversely correlates with platelet count. Br J Haematol. 2019 11; 187(3):e61-e64. PMID: 31487388.
    Citations:    Fields:    Translation:Humans
  76. Cheloff AZ, Al-Samkari H. Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease. J Blood Med. 2019; 10:313-321. PMID: 31565009.
    Citations: 8     
  77. Song AB, Rosovsky RP, Connors JM, Al-Samkari H. Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients. Vasc Health Risk Manag. 2019; 15:175-186. PMID: 31417269.
    Citations: 8     Fields:    Translation:Humans
  78. Al-Samkari H, Kuter DJ. Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia. Ther Adv Hematol. 2019; 10:2040620719841735. PMID: 31007886.
    Citations: 14     
  79. Al-Samkari H, Shin K, Cardoni L, Pighetti EH, Rits S, McMahon L, Perkins R, Uluer A, Connors JM. Antifibrinolytic Agents for Hemoptysis Management in Adults With Cystic Fibrosis. Chest. 2019 06; 155(6):1226-1233. PMID: 30790551.
    Citations: 5     Fields:    Translation:Humans
  80. Al-Samkari H, Patel AA, Schiano TD, Kuter DJ. Recurrence of Acute Intermittent Porphyria After Liver Transplantation. Ann Intern Med. 2019 06 18; 170(12):904-905. PMID: 30716770.
    Citations:    Fields:    Translation:Humans
  81. Al-Samkari H. Systemic Bevacizumab for Hereditary Hemorrhagic Telangiectasia: Considerations from Observational Studies. Otolaryngol Head Neck Surg. 2019 02; 160(2):368. PMID: 30798765.
    Citations: 3     Fields:    Translation:Humans
  82. Al-Samkari H. Optimal anticoagulant treatment of cancer-associated venous thromboembolism remains unclear. BMJ Evid Based Med. 2019 06; 24(3):115-116. PMID: 30518668.
    Citations:    Fields:    Translation:Humans
  83. Al-Samkari H, Van Cott EM, Kuter DJ. Platelet aggregation response in immune thrombocytopenia patients treated with romiplostim. Ann Hematol. 2019 Mar; 98(3):581-588. PMID: 30446804.
    Citations: 8     Fields:    Translation:Humans
  84. Al-Samkari H. Avatrombopag maleate for the treatment of periprocedural thrombocytopenia in patients with chronic liver disease. Drugs Today (Barc). 2018 Nov; 54(11):647-655. PMID: 30539164.
    Citations: 5     Fields:    Translation:HumansAnimals
  85. Nagrebetsky A, Al-Samkari H, Davis NM, Kuter DJ, Wiener-Kronish JP. Perioperative thrombocytopenia: evidence, evaluation, and emerging therapies. Br J Anaesth. 2019 Jan; 122(1):19-31. PMID: 30579402.
    Citations: 16     Fields:    Translation:Humans
  86. Al-Samkari H, Kritharis A, Rodriguez-Lopez JM, Kuter DJ. Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia. J Intern Med. 2019 02; 285(2):223-231. PMID: 30191646.
    Citations: 13     Fields:    Translation:Humans
  87. Al-Samkari H, Snyder GD, Nikiforow S, Tolaney SM, Freedman RA, Losman JA. Haemophagocytic lymphohistiocytosis complicating pembrolizumab treatment for metastatic breast cancer in a patient with the PRF1A91V gene polymorphism. J Med Genet. 2019 01; 56(1):39-42. PMID: 30287596.
    Citations: 5     Fields:    Translation:Humans
  88. Al-Samkari H, Kritharis A, Kuter DJ. Infections and vaccination in hereditary hemorrhagic telangiectasia: microbiological evidence-based considerations. Haematologica. 2018 10; 103(10):e492-e495. PMID: 30270207.
    Citations: 4     Fields:    Translation:Humans
  89. Al-Samkari H, Kuter DJ. Thrombopoietin level predicts response to treatment with eltrombopag and romiplostim in immune thrombocytopenia. Am J Hematol. 2018 12; 93(12):1501-1508. PMID: 30187942.
    Citations: 13     Fields:    Translation:Humans
  90. Al-Samkari H, Connors JM. The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis. Cancers (Basel). 2018 Aug 15; 10(8). PMID: 30111746.
    Citations: 12     
  91. Al-Samkari H, Kuter DJ. An alternative intermittent eltrombopag dosing protocol for the treatment of chronic immune thrombocytopenia. Br J Clin Pharmacol. 2018 11; 84(11):2673-2677. PMID: 30032487.
    Citations: 9     Fields:    Translation:Humans
  92. Al-Samkari H, Kuter DJ. Relative potency of the thrombopoietin receptor agonists eltrombopag, avatrombopag and romiplostim in a patient with chronic immune thrombocytopenia. Br J Haematol. 2018 10; 183(2):168. PMID: 29978577.
    Citations: 7     Fields:    Translation:Humans
  93. Al-Samkari H, Grace RF, Connors JM. Ofatumumab for acute treatment and prophylaxis of a patient with multiple relapses of acquired thrombotic thrombocytopenic purpura. J Thromb Thrombolysis. 2018 Jul; 46(1):81-83. PMID: 29564686.
    Citations: 3     Fields:    Translation:Humans
  94. Al-Samkari H, Croteau SE. Shifting Landscape of Hemophilia Therapy: Implications for Current Clinical Laboratory Coagulation Assays. Am J Hematol. 2018 Jun 08. PMID: 29884997.
    Citations: 4     Fields:    
  95. Kritharis A, Al-Samkari H, Kuter DJ. Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective. Haematologica. 2018 09; 103(9):1433-1443. PMID: 29794143.
    Citations: 28     Fields:    Translation:HumansAnimals
  96. Al-Samkari H, Marshall AL, Goodarzi K, Kuter DJ. Romiplostim for the management of perioperative thrombocytopenia. Br J Haematol. 2018 07; 182(1):106-113. PMID: 29767837.
    Citations: 8     Fields:    Translation:Humans
  97. Al-Samkari H, Connors JM. Dual anticoagulation with fondaparinux and dabigatran for treatment of cancer-associated hypercoagulability. Am J Hematol. 2018 06; 93(6):E156-E158. PMID: 29603336.
    Citations: 4     Fields:    Translation:Humans
  98. Al-Samkari H, Connors JM. Approach to Thrombophilia Testing in Patients with Splanchnic Vein Thrombosis. AME Med J. 2018; 3(7).
  99. Al-Samkari H, Marshall AL, Goodarzi K, Kuter DJ. The use of romiplostim in treating chemotherapy-induced thrombocytopenia in patients with solid tumors. Haematologica. 2018 04; 103(4):e169-e172. PMID: 29242295.
    Citations: 11     Fields:    Translation:Humans
  100. Al-Samkari H, Connors JM. Anticoagulation and Enzalutamide: Caution Over Convenience. J Oncol Pract. 2017 11; 13(11):728-729. PMID: 29125926.
    Citations: 1     Fields:    Translation:Humans
  101. Al-Samkari H, Berliner N. Hemophagocytic Lymphohistiocytosis. Annu Rev Pathol. 2018 01 24; 13:27-49. PMID: 28934563.
    Citations: 84     Fields:    Translation:Humans
  102. Phua PD, Al-Samkari HT, Borschel GH. Is the term "obstetrical brachial plexus palsy" obsolete? An international survey to assess consensus among peripheral nerve surgeons. J Plast Reconstr Aesthet Surg. 2012 Sep; 65(9):1227-32. PMID: 22512941.
    Citations: 1     Fields:    Translation:Humans
  103. Al-Samkari HT, Kane AA, Molter DW, Vachharajani A. Neonatal outcomes of Pierre Robin sequence: an institutional experience. Clin Pediatr (Phila). 2010 Dec; 49(12):1117-22. PMID: 20837617.
    Citations: 10     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Al-Samkari's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (261)
Explore
_
Co-Authors (58)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.